Suppr超能文献

慢性血液透析治疗影响下的血浆促红细胞生成素和血细胞比容(作者译)

[Plasma erythropoietin and hematocrit under the influence of chronic hemodialysis treatment (author's transl)].

作者信息

Schulz E, Mödder B, Rath K

出版信息

Klin Wochenschr. 1977 Jan 15;55(2):65-9. doi: 10.1007/BF01469084.

Abstract

Hematocrit and plasma ESF titers were determined at 2 to 3 weeks intervals in 21 patients with chronic renal failure prior to and during a 15-weeks' period following initiation of chronic intermittent hemodialysis. While hematocrits increased from 22 to 27%, plasma ESF titers were found unchanged between 31 and 35 mU/ml. It can be excluded therefore that the improvement of erythropoiesis following initiation of dialysis was in part due to an increase in plasma ESF titers. The increased erythropoiesis observed is probably not dependent on increased ESF production. A 30-fold ESF deficit existed in patients with renal failure prior to the initiation of hemodialysis when compared with 5 patients with aplastic anemia (hematocrit 23%, plasma ESF titer 1115 mU/ml). At one exception ESF titers up to 500 mU/ml were found in dialysed patients only in combination with anemia due to acute bleeding or iron deficiency. ESF production is appropiate to the degree of anemia in patients with proper renal function after kidney transplantation.

摘要

在21例慢性肾衰竭患者开始慢性间歇性血液透析之前及之后的15周期间,每隔2至3周测定血细胞比容和血浆促红细胞生成素(ESF)滴度。血细胞比容从22%升至27%,而血浆ESF滴度在31至35 mU/ml之间未发现变化。因此可以排除透析开始后红细胞生成的改善部分归因于血浆ESF滴度增加的可能性。观察到的红细胞生成增加可能不依赖于ESF产生的增加。与5例再生障碍性贫血患者(血细胞比容23%,血浆ESF滴度1115 mU/ml)相比,慢性肾衰竭患者在开始血液透析前存在30倍的ESF缺乏。仅在因急性出血或缺铁性贫血的透析患者中发现ESF滴度高达500 mU/ml的情况(有1例例外)。肾移植后肾功能正常的患者,其ESF产生与贫血程度相符。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验